CN109288959A - 益心舒片及其制备方法 - Google Patents
益心舒片及其制备方法 Download PDFInfo
- Publication number
- CN109288959A CN109288959A CN201811297758.0A CN201811297758A CN109288959A CN 109288959 A CN109288959 A CN 109288959A CN 201811297758 A CN201811297758 A CN 201811297758A CN 109288959 A CN109288959 A CN 109288959A
- Authority
- CN
- China
- Prior art keywords
- weight
- parts
- obtains
- invigorating heart
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 62
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 18
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 18
- 235000008434 ginseng Nutrition 0.000 claims abstract description 18
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 11
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 11
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 11
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 11
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 11
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 11
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 11
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 11
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 11
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 11
- 240000006079 Schisandra chinensis Species 0.000 claims abstract description 11
- 235000008422 Schisandra chinensis Nutrition 0.000 claims abstract description 11
- 239000009636 Huang Qi Substances 0.000 claims abstract description 10
- 235000020985 whole grains Nutrition 0.000 claims abstract description 7
- 240000000171 Crataegus monogyna Species 0.000 claims abstract 3
- 235000019441 ethanol Nutrition 0.000 claims description 35
- 239000006071 cream Substances 0.000 claims description 27
- 239000000843 powder Substances 0.000 claims description 20
- 241000208340 Araliaceae Species 0.000 claims description 17
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 16
- 239000000284 extract Substances 0.000 claims description 15
- 239000000706 filtrate Substances 0.000 claims description 13
- 238000010992 reflux Methods 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 10
- 238000001914 filtration Methods 0.000 claims description 10
- 235000019359 magnesium stearate Nutrition 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- 229920002472 Starch Polymers 0.000 claims description 7
- 239000008107 starch Substances 0.000 claims description 7
- 235000019698 starch Nutrition 0.000 claims description 7
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 5
- 239000000463 material Substances 0.000 claims description 5
- 238000004064 recycling Methods 0.000 claims description 5
- 239000013049 sediment Substances 0.000 claims description 5
- 239000000377 silicon dioxide Substances 0.000 claims description 5
- 239000011734 sodium Substances 0.000 claims description 5
- 229910052708 sodium Inorganic materials 0.000 claims description 5
- 239000003814 drug Substances 0.000 abstract description 8
- 238000000605 extraction Methods 0.000 abstract description 7
- 239000002245 particle Substances 0.000 abstract description 4
- 241000196324 Embryophyta Species 0.000 abstract description 2
- 238000005469 granulation Methods 0.000 abstract description 2
- 230000003179 granulation Effects 0.000 abstract description 2
- 239000002994 raw material Substances 0.000 abstract description 2
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 241001092040 Crataegus Species 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 201000010099 disease Diseases 0.000 description 6
- 208000024172 Cardiovascular disease Diseases 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 208000026106 cerebrovascular disease Diseases 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000002526 effect on cardiovascular system Effects 0.000 description 3
- 239000009877 shengmai Substances 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000002386 leaching Methods 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 210000000115 thoracic cavity Anatomy 0.000 description 2
- 239000011800 void material Substances 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 239000002389 essential drug Substances 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229940074869 marquis Drugs 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- VBUNOIXRZNJNAD-UHFFFAOYSA-N ponazuril Chemical compound CC1=CC(N2C(N(C)C(=O)NC2=O)=O)=CC=C1OC1=CC=C(S(=O)(=O)C(F)(F)F)C=C1 VBUNOIXRZNJNAD-UHFFFAOYSA-N 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 208000037975 work-related injury Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种益心舒片及其制备方法,具体由人参、麦冬、五味子、黄芪、丹参、川芎、山楂为原料,提取制备而成,该片剂的制备,以75%乙醇制粒,其粘性较强,适用于质地疏松、弹性较强的植物性药物,制得的颗粒经整粒后,片子硬度,口感好,压片制成片剂后片面光滑平整,具备良好的运用价值。
Description
技术领域
本发明涉及中成药片剂及其制备领域,具体涉及一种益心舒片及其制备方法。
背景技术
心脑血管疾病是目前影响人类健康,造成死亡的最重要因素之一,据文献报道,每年全世界死于心脑血管疾病的人数超过2000万,我国近40万。中医在该病的诊治方面积累了丰富的临床经验,中药方剂在治疗心脑血管疾病方面具有独特的优势。胸痛及冠心病心绞痛属中医“胸痹”范畴。胸痹其病因与寒邪内侵、饮食不当、情志失调、年迈体虚等有关,按证候可分为心血瘀阻、痰浊雍塞、阴寒凝滞、心肾阴虚、气阴两虚、阳气虚衰等症型。“心脉痹阻”为本病的主要病理机制,临床大多虚实夹杂,呈本虚表实之候,治疗此病倡用以补为主以,通为用原则,补,主要补气阴,旨在调脏腑气血偏盛偏衰,以治本虚之证,通,主要活血通阳,意在宣通脉络之痹阻,以治标实之侯。
益心舒胶囊处方以古方“生脉饮”加味活血药而成,标本兼治。“生脉饮”为治疗胸痹常用基础方,以生脉饮加味在冠心病临床研究方面有众多文献见诸报道,疗效显著。益心胶囊属于国家基本药物(2004年),同时又属于《基本医疗保险和工伤保险药品目录》2004年版中成药乙类,效果良好,服用方便,深受广大患者青睐。
公开号为103784726A的中国专利申请中公开了一种益心舒片的制备方法,该方法操作过程中乙醇浓度越大,湿润后粘性越低,造成制得的湿颗粒目数分布范围广而不均匀、细粉多,造成压片时出现花片、裂片等现象,制得的益心舒片崩解时间长且在储藏一段时间后会出现崩解时限不合格、稳定性差、微生物不合格等现象。
发明内容
本发明提供了一种益心舒片,该益心舒片崩解时限短、微生物限度合格,该制备方法工序简单、质量可控且适于工业化生产,具体内容如下:
一种益心舒片,以10000片计,由益心舒干膏及其辅料压片制成,所述的益心舒干膏是以200~280重量份人参、200~250重量份麦冬、100~135重量份五味子、140~200重量份黄芪、200~300重量份丹参、100~180重量份川芎、180~250重量份山楂为原料提取而成的;
上述的一种益心舒片,所述的益心舒干膏的制备方法如下:
(1)将人参粉碎后得到人参细粉,备用;
(2)将五味子、丹参用70~85%的乙醇回流提取2次,得到的提取液滤过,合并后减压浓缩至密度为1.15~1.12得到醇浸膏A;
(3)将麦冬、黄芪、川芎和山楂用水煎煮2次,合并煎液,滤过,滤液浓缩至原体积的10~12%,再加入95%的乙醇,充分搅拌后,静置过夜,滤去沉淀物,滤液回收乙醇并浓缩至相对密度1.15~1.25,得到浸膏B;
(4)将醇浸膏A和浸膏B合并后加入步骤(1)得到的人参细粉后混匀得到所述的益心舒干膏。
上述的益心舒片的制备方法,包括以下步骤:
(1)取处方量的益心舒干膏粉碎过100目筛,加入适量淀粉充分混匀、备用;
(2)将二氧化硅、羧甲淀粉钠、1~5%重量的益心舒干膏粉采用等量递增法混合均匀,得到原辅料;
(3)按上述益心舒干膏粉用75%的乙醇一步制粒,在70℃条件下烘干,整粒,再加入1%-1.5%硬脂酸镁得到的原辅料混合均匀,压片得到所述的益心舒片。
同现有技术相比,本发明的有益效果体现在:
1)以75%乙醇制粒,其粘性较强,适用于质地疏松、弹性较强的植物性药物,制得的颗粒经整粒后,片子硬度,口感好,压片制成片剂后片面光滑平整,崩解时限等指标都符合要求。
2)通过辅料的精心筛选,所制成的颗粒粒度均匀,释放度,口感好、崩解时限、片子光洁度方面都有优于传统工艺制成的颗粒。
3)该方法制备时间短、物料损耗少、劳动强度低、受外界污染低和成品颗粒整齐,只需配备少量人员,更合适以规模化生产。
具体实施方式
以下通过实施例进一步解释或是说明本发明内容,但是所提供的实施例不应被理解为对本发明保护范围构成限制。
实施例1
处方:1500g人参、1500g麦冬、950g五味子、1500g黄芪、2400g丹参、950g川芎、1500g山楂
制备方法:(1)以上七味,取1500g人参粉碎细粉后备用。950g五味子、2400g丹参用85%的乙醇回流提取2次,第一次加85%乙醇6倍量,回流提取3小时,第二次加95%乙醇5倍量,回流提取1.5小时,滤过,合并滤液,减压浓缩至相对密度1.15~1.12(20℃),得醇浸膏。再将1500g麦冬、1500g黄芪、950g川芎和1500g山楂加水煎煮2次,第一次加水10倍量(重量),煎煮2.5小时,第二次加水8倍量,煎煮1.5小时,合并煎液,滤过,滤液浓缩至3500ml,加入等量的85%乙醇,充分搅拌后,静置过夜,滤去沉淀物,滤液回收乙醇并浓缩至相对密度1.15(80℃),将上述二种浸膏合并后再加入人参细粉混合均匀得到益心舒干膏,备用。
(2)益心舒干膏粉碎过100目筛,蔗糖粉碎过80目筛,备用。
(3)将二氧化硅40g、硬脂酸镁25g、羧甲淀粉钠90g、益心舒干膏粉50g混合均匀,备用。
(4)按上述益心舒干膏粉用75%的乙醇一步制粒,在70℃条件下烘干,整粒,再加入1%-1.5%硬脂酸镁得到的原辅料混合均匀,压片得到所述的益心舒片。
实施例2
处方:1200g人参、1500g麦冬、1000g五味子、1200g黄芪、2000g丹参、1000g川芎、1200g山楂
制备方法:(1)以上七味,取1200g人参粉碎细粉后备用。1000g五味子、2000g丹参用85%的乙醇回流提取2次,第一次加85%乙醇6倍量,回流提取3小时,第二次加95%乙醇5倍量,回流提取1.5小时,滤过,合并滤液,减压浓缩至相对密度1.15~1.12(20℃),得醇浸膏。再将1500g麦冬、1200g黄芪、1000g川芎和1200g山楂加水煎煮2次,第一次加水10倍量(重量),煎煮2.5小时,第二次加水8倍量,煎煮1.5小时,合并煎液,滤过,滤液浓缩至3500ml,加入等量的85%乙醇,充分搅拌后,静置过夜,滤去沉淀物,滤液回收乙醇并浓缩至相对密度1.15(80℃),将上述二种浸膏合并后再加入人参细粉混合均匀得到益心舒干膏,备用。
(2)益心舒干膏粉碎过100目筛,蔗糖粉碎过80目筛,备用。
(3)将二氧化硅40g、硬脂酸镁25g、羧甲淀粉钠90g、益心舒干膏粉50g混合均匀,备用。
(4)按上述益心舒干膏粉用75%的乙醇一步制粒,在70℃条件下烘干,整粒,再加入1%-1.5%硬脂酸镁得到的原辅料混合均匀,压片得到所述的益心舒片。
实施例3
处方:1800g人参、1600g麦冬、1100g五味子、1400g黄芪、2200g丹参、1100g川芎、1300g山楂
制备方法:(1)以上七味,取1800g人参粉碎细粉后备用。1100g五味子、2200g丹参用85%的乙醇回流提取2次,第一次加85%乙醇6倍量,回流提取3小时,第二次加85%乙醇5倍量,回流提取1.5小时,滤过,合并滤液,减压浓缩至相对密度1.15~1.12(20℃),得醇浸膏。再将1600g麦冬、1400g黄芪、1100g川芎和1300g山楂加水煎煮2次,第一次加水10倍量(重量),煎煮2.5小时,第二次加水8倍量,煎煮1.5小时,合并煎液,滤过,滤液浓缩至3500ml,加入等量的85%乙醇,充分搅拌后,静置过夜,滤去沉淀物,滤液回收乙醇并浓缩至相对密度1.15(80℃),将上述二种浸膏合并后再加入人参细粉混合均匀得到益心舒干膏,备用。
(2)益心舒干膏粉碎过100目筛,蔗糖粉碎过80目筛,备用。
(3)将二氧化硅40g、硬脂酸镁25g、羧甲淀粉钠90g、益心舒干膏粉50g混合均匀,备用。
(4)按上述益心舒干膏粉用75%的乙醇一步制粒,在70℃条件下烘干,整粒,再加入1%-1.5%硬脂酸镁得到的原辅料混合均匀,压片得到所述的益心舒片。
Claims (3)
1.一种益心舒片,以10000片计,由益心舒干膏及其辅料压片制成,其特征在于:所述的益心舒干膏是以200~280重量份人参、200~250重量份麦冬、100~135重量份五味子、140~200重量份黄芪、200~300重量份丹参、100~180重量份川芎、180~250重量份山楂为原料提取而成的;
2.根据权利要求1所述的一种益心舒片,所述的益心舒干膏的制备方法如下:
(1)将人参粉碎后得到人参细粉,备用;
(2)将五味子、丹参用70~85%的乙醇回流提取2次,得到的提取液滤过,合并后减压浓缩至密度为1.15~1.12得到醇浸膏A;
(3)将麦冬、黄芪、川芎和山楂用水煎煮2次,合并煎液,滤过,滤液浓缩至原体积的10~12%,再加入95%的乙醇,充分搅拌后,静置过夜,滤去沉淀物,滤液回收乙醇并浓缩至相对密度1.15~1.25,得到浸膏B;
(4)将醇浸膏A和浸膏B合并后加入步骤(1)得到的人参细粉后混匀得到所述的益心舒干膏。
3.根据权利要求1或2所述的益心舒片的制备方法,包括以下步骤:
(1)取处方量的益心舒干膏粉碎过100目筛,加入适量淀粉充分混匀、备用;
(2)将二氧化硅、羧甲淀粉钠、1~5%重量的益心舒干膏粉采用等量递增法混合均匀,得到原辅料;
(3)按上述原辅料用75%的乙醇一步制粒,在70℃条件下烘干,整粒,再加入1%-1.5%硬脂酸镁得到的原辅料混合均匀,压片得到所述的益心舒片。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811297758.0A CN109288959A (zh) | 2018-11-01 | 2018-11-01 | 益心舒片及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811297758.0A CN109288959A (zh) | 2018-11-01 | 2018-11-01 | 益心舒片及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109288959A true CN109288959A (zh) | 2019-02-01 |
Family
ID=65146258
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811297758.0A Pending CN109288959A (zh) | 2018-11-01 | 2018-11-01 | 益心舒片及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109288959A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111388594A (zh) * | 2020-04-21 | 2020-07-10 | 广东先通药业有限公司 | 益心舒片组合物有效成分的萃取及其质量鉴别方法 |
-
2018
- 2018-11-01 CN CN201811297758.0A patent/CN109288959A/zh active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111388594A (zh) * | 2020-04-21 | 2020-07-10 | 广东先通药业有限公司 | 益心舒片组合物有效成分的萃取及其质量鉴别方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101653553A (zh) | 一种益心安神颗粒 | |
CN101972368B (zh) | 山菊降压颗粒制备工艺 | |
CN104740308A (zh) | 一种医用生物降血糖口服液及其制备方法 | |
CN109288959A (zh) | 益心舒片及其制备方法 | |
CN1054370A (zh) | 一种补肾强身药剂的制造方法 | |
CN104206595A (zh) | 一种降脂降糖的地骨皮保健茶及其制备方法 | |
CN101780242A (zh) | 一种保健或药品组合物及其制备方法和用途 | |
CN101279034B (zh) | 一种内服和外用结合治疗糖尿病的组合中药及制备方法 | |
CN101473940A (zh) | 一种功能性抑郁症保健食品及其制备方法 | |
CN108815391A (zh) | 一种肝损伤保护功能的双石斛提取物的制备工艺 | |
CN103784726B (zh) | 益心舒片及其制备方法 | |
CN104524477A (zh) | 一种治疗结节性甲状腺肿的中药组合物 | |
CN100409880C (zh) | 一种治疗高脂血症的蒙药保利尔及其制备方法 | |
CN102614457A (zh) | 一种乳康片的制备方法 | |
CN105878712A (zh) | 一种补心安神的中药组合物及其制备方法 | |
CN110882382A (zh) | 一种含有sod组份的养生药酒及其制备方法 | |
CN105878710A (zh) | 一种滋养阴血安神补心的中药组合物及其制备方法 | |
CN105012522A (zh) | 一种滋肾健脑的中药、制备方法及用途 | |
CN104721528A (zh) | 一种滋阴养血补心安神的中药组合物及其制备方法 | |
CN1151813C (zh) | 一种治疗不眠症的中药组合物 | |
CN103520253A (zh) | 一种治疗劳损虚损症的药物及其制备方法 | |
CN105687365A (zh) | 一种治疗多发性肌炎的中药组合物及其制备方法和用途 | |
CN105767312A (zh) | 一种降压保健茶及其制备方法 | |
CN106668506A (zh) | 茯苓银杏含片 | |
CN115919969A (zh) | 一种治疗高血压的黄芪党参组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20190201 |